Clinical Trials Logo

Acute Gastritis clinical trials

View clinical trials related to Acute Gastritis.

Filter by:
  • None
  • Page 1

NCT ID: NCT05048069 Recruiting - Chronic Gastritis Clinical Trials

Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.

MCTSRPMS
Start date: October 7, 2021
Phase:
Study type: Observational

This PMS is a non-interventional, prospective, single-arm, multi-center surveillance in accordance with Korean regulation, 'Standard for Re-Examination of New Drugs'. This PMS is to assess the safety and effectiveness after administrating Mucosta®SR Tab. Each subject would be observed for 2 weeks from baseline, if possible. As this PMS is an observational study in practical medical environment, the subject's follow-up is recommended but not obligatory and must be left up to the judgment of the investigator.

NCT ID: NCT04341454 Completed - Chronic Gastritis Clinical Trials

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

Start date: June 2, 2020
Phase: Phase 3
Study type: Interventional

The purpose of study is to confirm the efficacy of DWP14012 X mg QD, DWP14012 Y mg BID compared to placebo in patients with Acute or Chronic Gastritis

NCT ID: NCT04189705 Completed - Chronic Gastritis Clinical Trials

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

Start date: December 30, 2019
Phase: Phase 3
Study type: Interventional

This is a multi-center, randomized, double-blind, active-controlled, non-inferiority, phase 3 study to evaluate the efficacy and safety of MCT-SR in patients with gastritis.

NCT ID: NCT04066530 Completed - Chronic Gastritis Clinical Trials

A Study to Evaluate the Efficacy and Safety of AD-203

Start date: September 23, 2019
Phase: Phase 3
Study type: Interventional

This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compared with Mucosta tab. in patients with acute or chronic gastritis

NCT ID: NCT02356679 Completed - Chronic Gastritis Clinical Trials

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

Start date: August 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is evaluate the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients.

NCT ID: NCT02282670 Unknown status - Chronic Gastritis Clinical Trials

A Study to Evaluate the Efficacy and Safety of DA-5204

Start date: April 2014
Phase: Phase 3
Study type: Interventional

This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of DA-5204 and to demonstrate the non-inferiority of DA-5204 compared with Stillen® tab. in patients with acute or chronic gastritis.

NCT ID: NCT01817556 Completed - Chronic Gastritis Clinical Trials

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

Start date: October 2012
Phase: Phase 4
Study type: Interventional

This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy of 4-week treatment with Stillen tab. in patients with acute or chronic gastritis. Subject will receive Stillen tab or Mucosta tab., three times a day for four weeks.

NCT ID: NCT01813812 Recruiting - Chronic Gastritis Clinical Trials

A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034

Start date: October 2010
Phase: Phase 3
Study type: Interventional

This is a multicenter, double-blinded, double-dummy, active-controlled, randomized, Phase III clinical trial to evaluate the efficacy and safety of DA-6034 and to demonstrate the non-inferiority of DA-6034 compared with Rebamipide in patients with acute or chronic gastritis. Subjects will receive 45mg, 90mg of DA-6034 and 300mg of Rebamipide, two tablets, three times a day for two weeks.

NCT ID: NCT01190657 Completed - Gastric Ulcer Clinical Trials

Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer

Start date: May 2010
Phase: Phase 4
Study type: Interventional

This is a self-controlled, open, multiple-center clinical trial.